PHARMDEKO Stock Overview
Pharma Deko Plc engages in manufacturing, packaging, and marketing pharmaceutical and consumer products in Nigeria.
Pharma-Deko Plc Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₦1.83|
|52 Week High||₦2.37|
|52 Week Low||₦1.71|
|1 Month Change||0%|
|3 Month Change||0%|
|1 Year Change||-1.08%|
|3 Year Change||22.00%|
|5 Year Change||20.39%|
|Change since IPO||-37.11%|
Recent News & Updates
|PHARMDEKO||NG Beverage||NG Market|
Return vs Industry: PHARMDEKO underperformed the NG Beverage industry which returned 2.9% over the past year.
Return vs Market: PHARMDEKO underperformed the NG Market which returned 54.9% over the past year.
|PHARMDEKO Average Weekly Movement||0%|
|Beverage Industry Average Movement||5.4%|
|Market Average Movement||5.8%|
|10% most volatile stocks in NG Market||10.0%|
|10% least volatile stocks in NG Market||3.3%|
Stable Share Price: Insufficient data to determine PHARMDEKO's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine PHARMDEKO's volatility change over the past year.
About the Company
Pharma Deko Plc engages in manufacturing, packaging, and marketing pharmaceutical and consumer products in Nigeria. It operates through three segments: Pharma, Consumer, and Contract. The company offers pharmaceutical products, such as Vitacee syrups and drops, Pharmadec syrups and drops, Brett mouthwash, Hexedene oral care medication, Parkalin range of cough syrup, Parkaling Pediatrics, Revitone Blood Tonic, Salins Liniment, Antasil tablets, Omepraz capsules, and Parkaprim tablets and suspension; and Sparxin, Pidiclox dry powder and capsules, and Amycin dry powder and capsules, as well as paracetamol under the Phardol Drops brand.
Pharma-Deko Plc Fundamentals Summary
|PHARMDEKO fundamental statistics|
Is PHARMDEKO overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|PHARMDEKO income statement (TTM)|
|Cost of Revenue||₦435.21m|
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.65|
|Net Profit Margin||-30.16%|
How did PHARMDEKO perform over the long term?See historical performance and comparison